Prakhova Lidiia, Lebedev Valeriy, Ilves Aleksandr, Nazinkina Yulia
N.P. Bechtereva Institute of the Human Brain of the Russian Academy of Sciences, Saint-Petersburg, Russian Federation
N.P. Bechtereva Institute of the Human Brain of the Russian Academy of Sciences, Saint-Petersburg, Russian Federation.
BMJ Case Rep. 2021 Mar 24;14(3):e237726. doi: 10.1136/bcr-2020-237726.
Monoclonal gammopathy of undetermined significance (MGUS)-associated involvement of the peripheral nervous system is widely reported in the literature. At the same time, involvement of central nervous system (CNS) occurs far less frequently. Analysing the reported cases, almost all the authors pose the question whether there is a relationship between CNS involvement and MGUS, and at what stage it is necessary to begin therapy of haematological disorders. The limited number of reported cases precludes us from getting a definite answer to these questions, thus making further accumulation of clinical data highly relevant. In this article, we present two cases of CNS involvement in patients with MGUS, which, in our opinion, may suggest the existence of a causal relationship between MGUS and CNS involvement. Currently, the above hypothesis cannot be taken as proved due to the lack of a sufficient number of clinical observations and scientific studies. Therefore, the issue of MGUS-associated CNS involvement requires further research.
意义未明的单克隆丙种球蛋白病(MGUS)相关的周围神经系统受累在文献中有广泛报道。与此同时,中枢神经系统(CNS)受累的情况则要少见得多。分析已报道的病例,几乎所有作者都提出了这样的问题:CNS受累与MGUS之间是否存在关联,以及在哪个阶段有必要开始血液系统疾病的治疗。报道病例数量有限,使我们无法对这些问题给出明确答案,因此进一步积累临床数据具有高度相关性。在本文中,我们介绍了两例MGUS患者出现CNS受累的病例,我们认为这可能提示MGUS与CNS受累之间存在因果关系。目前,由于缺乏足够数量的临床观察和科学研究,上述假设尚不能被视为已得到证实。因此,MGUS相关的CNS受累问题需要进一步研究。